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Abstract
Background: The assessment of quality of care is an integral part of modern medicine. The referral represents the
handing over of care from the general practitioner to the specialist. This study aimed to assess whether an
improved referral could lead to improved quality of care.
Methods: A cluster randomized trial with the general practitioner surgery as the clustering unit was performed.
Fourteen surgeries in the area surrounding the University Hospital of North Norway Harstad were randomized
stratified by town versus countryside location. The intervention consisted of implementing referral templates for
new referrals in four clinical areas: dyspepsia; suspected colorectal cancer; chest pain; and confirmed or suspected
chronic obstructive pulmonary disease. The control group followed standard referral practice. Quality of treatment
pathway as assessed by newly developed quality indicators was used as main outcome. Secondary outcomes
included subjective quality assessment, positive predictive value of referral and adequacy of prioritization.
Assessment of outcomes was done at the individual level. The patients, hospital doctors and outcome assessors
were blinded to the intervention status.
Results: A total of 500 patients were included, with 281 in the intervention and 219 in the control arm. From the
multilevel regression model the effect of the intervention on the quality indicator score was insignificant at 1.80%
(95% CI, −1.46 to 5.06, p = 0.280). No significant differences between the intervention and the control groups were
seen in the secondary outcomes. Active use of the referral intervention was low, estimated at approximately 50%.
There was also wide variation in outcome scoring between the different assessors.
Conclusions: In this study no measurable effect on quality of care or prioritization was revealed after
implementation of referral templates at the general practitioner/hospital interface. The results were hindered by a
limited uptake of the intervention at GP surgeries and inconsistencies in outcome assessment.
Trial registration: The study was registered under registration number NCT01470963 on September 5th, 2011.
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Background
Quality of care is now an integral part of modern medicine,
exemplified most recently in Norway by the National Pa-
tient Safety Programme [1], a national strategy for quality
improvement in health and social services [2], and several
national registries [3, 4]. To define quality in health care,
though, is challenging because of its subjective nature [5].
The definition by Donabedian is “the application of medical
science and technology in a manner that maximises its
benefit to health without correspondingly increasing the
risk” [6]; in many ways this represents what many physi-
cians regard as high-quality care. Others have highlighted
the need to take patient expectations and financial con-
straints into account in the definition of quality of care [7].
Measurement of quality is important both to ensure
the quality of services and to aid hospital management.
Several authors have highlighted the usefulness of qual-
ity measurement in documenting the quality of care,
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making comparisons, prioritizing, quality improvement,
and accountability [8, 9]. However, as indicated in a re-
cent editorial, care must be taken to ensure that qual-
ity—not the measuring of quality—remains the aim [10].
Quality measures are usually classified as structural,
process, or outcome measures [11]. Structural measures
are often easy to evaluate, and examples include equip-
ment, facility, and staffing numbers. However, they tend
to be weakly associated with outcomes [12]. Process
measures are the components of the encounter between
the patient and health-care professional, such as ordered
tests [9, 13]. They aim to assess how often an interven-
tion known to correlate with a favourable outcome takes
place. Outcome measures use the health outcome, such
as survival, complications, and quality of life, as a quality
indicator [12]. The use of outcome measures is impeded
by several factors, such as the infrequent occurrence of
some events (e.g. mortality and morbidity), and the fact
that the interval between intervention and event may
extend for years [12, 14].
Many quality criteria have been developed [15–18],
often following the RAND Corporation/UCLA (University
of California) appropriateness method [19], but other
methods have also been described [20, 21]. A perfect qual-
ity measure would fully correlate with positive outcomes
for each individual patient. However, an error-free meas-
ure of quality of care is unlikely ever to be created [9].
Quality indicators are only “tools that can support quality
improvement”—not necessarily direct measures of quality
[22]. Some authors have expressed concern about quality
measures that focus on small aspects of care; they fear that
other aspects of equal, or greater, importance may receive
less attention [23, 24]. In a recent article, Bishop empha-
sized that quality measurement in outpatient care is in-
complete and that the focus is mainly on preventive care,
chronic disease management, and patient experience [25].
Similarly, a review of performance measures in the
specialist referral process identified multiple measures
[26]; most of these concentrated, though, on the
structural components of the referral process—as op-
posed to holistically depicting the quality of the entire
treatment process.
The referral constitutes the handing over of care from
one caregiver to another. For the purpose of this paper
referral is defined as the handing over of care from the
general practitioner (GP) to secondary care. To assure
high quality further down in the treatment process, the
referral letter from the GP should contain all the neces-
sary information in a context of shared understanding
among the GP, the patient, and hospital staff [27]. How-
ever, a number of publications have pointed to the vary-
ing quality and content of referrals in clinical practice
[28–30]. Over the years, many interventions have been
directed at the referral process. A Cochrane review on
this subject indicates the complexities of research in this
field and states that surprisingly few interventions on
the referral system have been rigorously evaluated [31].
In Norway, the health-care system is relatively uniform
throughout the country. Each GP has a list of patients
for whom he/she provides care. GPs act as gatekeepers
to secondary care [32]. Specialist health care is delivered
through governmentally owned regional health authori-
ties—mainly via public hospitals, but private health care is
available to some extent. Communication between GPs
and hospitals is almost exclusively electronic, with the
automatic retrieval of demographic information, such as
addresses, contact details, and GP details in each referral,
according to a national standard [33]. Apart from this
automatic retrieval referrals are, in normal practice,
mainly written in free text format containing the informa-
tion each referring GP deem necessary. Beyond basic de-
mographical information the referrals therefore contain
varying amount and type of clinical information.
According to several of the aspects indicated in the
Cochrane report mentioned above [31], the current study
is an attempt to evaluate a referral intervention in a set-
ting with a well-organized GP care system electronically
linked to the local hospital. Those aspects include referral
quality, secondary-care management of patients, and pa-
tient outcomes and satisfaction. We have previously
shown that the quality of the referrals in the intervention
group improved by 18% (95% CI 11, 25), p < 0.001 [34].
This increase however, is of limited value unless it trans-
lates into a measurable change in outcomes that matter to
patients and caregivers. The current article presents the
effect of this increase in referral quality as measured by
the assessment of individual patient pathways by quality
of care indicators and other secondary measurements.
The aim is to assess if an improvement that seem pertin-
ent, given the referral deficiencies discussed above, also
translate into a measurable care difference for the individ-
ual patient.
Methods
Study design
This study was designed as a cluster-randomized trial with
the GP surgery as the clustering unit. The 14 community
GP surgeries in the area served by the medical department
at the University Hospital of North Norway Harstad
(UNN Harstad) were randomized to an intervention or
control group. We chose the cluster-randomized design to
avoid potential “contamination” between GPs at the same
surgery—as could have occurred with individual GP
randomization. Randomisation was done by simple draw-
ing by a person not connected to the research team, strati-
fied by town vs countryside location of surgery.
Patients, hospital doctors, and outcome evaluators
were blinded to the intervention status of the patient;
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participating GPs could not be blinded since they ac-
tively used the intervention. Further details about the
randomization and study methods are described else-
where [35].
Intervention
The intervention consisted of the distribution of referral
templates—in electronic and paper form—to be used as
reference sheets when initiating a new referral to med-
ical outpatients at UNN Harstad. The GPs could choose
whether to use the electronic template directly or use
the paper template as a reference, when initiating a new
referral. The templates were to be used with the referral
of new patients in four separate clinical areas: dyspepsia;
suspected colorectal cancer; chest pain; and confirmed
or suspected chronic obstructive pulmonary disease
(COPD). We developed the referral templates based
upon national and international literature in collabor-
ation with local specialists in each medical field. To en-
sure the appropriateness of the templates, we also
obtained assessments from specialists at other Norwe-
gian hospitals. To promote adoption of the intervention,
we included only information perceived as imperative in
the referrals in the final templates. As an example, the
items in the referral template for patients with dyspepsia
appear in Table 1; other templates are available on re-
quest. The templates were distributed at educational or
lunch meetings, and follow-up visits were provided twice
a year during the inclusion phase. It was intended that
the intervention referrals within the project would be
sent to a specific electronic address at UNN Harstad to
enable assessment of intervention uptake. The interven-
tion was in use from September 2011 to November 2013
and stopped after the planned period of approximately
2 years [35]. The control group followed normal referral
practice.
Participants
We included all 14 GP surgeries in the geographical area
served by UNN Harstad in the randomization process.
In 2013, they had a total list size of 39,253 patients. Indi-
vidual consecutive patients referred from these GP sur-
geries received study information and a consent form
together with their appointment letter from the hospital.
They received an oral reminder regarding study partici-
pation at their first hospital appointment. Children
(<18 years of age) and patients with reduced capacity to
consent were excluded from the project. Patients were
recruited from September 2011 until February 2014.
Further details about the randomization and recruitment
processes are described elsewhere [35].
Sample size
In the actual study, the intraclass correlation coefficient
(ICC) turned out to be 0.02 (95% CI, 0.00–0.06). Esti-
mating the sample size based on the study effect esti-
mates and this ICC with the assumption of 80% power
to detect a 10% difference with a p value set at 0.05 leads
to a total sample size of 94 (84, 124). To detect a 5% dif-
ference, a total sample size of 576 (324, unattainable
with only 14 clusters) would seem appropriate.
Data
We retrieved data by manual review of the electronic
health records. Electronic retrieval was considered, but
seen as too complex and imprecise for clinical quality
indicators—a conclusion that has also been made by
others [36].
Outcomes
The present study aimed to assess the quality of the care
pathway by the following outcomes measures as outlined
in our previous paper [35] and further detailed below.
 Quality indicator score
 Specialist’s subjective quality assessment
 Positive predictive value of referral
 Adequacy of prioritization
Quality indicator score
Reviewing the literature few relevant quality indicators
assessing information from individual patient’s pathways
were found. The quality indicators used to assess quality
Table 1 Referral template for patients referred with dyspepsia
Item no. Text item
1 Dysphagia
2 Odynophagia
3 Anorexia
4 Weight loss
5 Haematemesis
6 Melaena
7 Vomiting
8 Medications (especially NSAIDa,
acetylsalicylic acid, bisphosphonates)
9 Nocturnal symptoms
10 Symptom duration
11 Previous peptic ulcer disease
12 Previous upper gastrointestinal
tract operations
13 Jaundice
14 Cervical lymphadenopathy
15 Hepatomegaly
16 Anaemia
17 If <50 years, Helicobacter pylori status
aNSAID non-steroidal anti-inflammatory drugs
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of care were therefore developed from previous quality-
assessment tools and treatment guidelines [13, 16, 18,
37–68]. The indicators were mainly process indicators.
Some adaptation was made to align the criteria with lo-
cally accepted practice, which has been demonstrated
elsewhere when transferring quality criteria to a new
context [69]. The indicators were assessed by specialists
in the appropriate field and reviewed based on the advice
received. However, no formal approach was employed in
developing the indicators. The full indicators are available
on request, and the set for dyspepsia is available in a trans-
lated version as Additional file 1.
Each patient care pathway was scored according to the
criteria. The indicator set for each clinical area consisted
of a general section and disease specific subsections de-
pending on the final diagnosis in the treatment pathway.
Scoring was undertaken by a panel of specialists from
different Norwegian hospitals—all blinded to the inter-
vention status of the patient. Eight gastroenterologists,
two cardiologists, and two pulmonologists participated.
All scorers were independent from the GP surgeries and
the hospital involved in the study. To allow assessment
of scoring agreement, a subsample of the cases was eval-
uated by two scorers independently.
The quality indicator score was calculated as an adher-
ence score (number of criteria met divided by number of
applicable criteria), as developed by Ashton et al. [70]. If
insufficient information was available to ascertain whether
or not an applicable criterion was met, it was classed as
“not met” [71], thereby producing a conservative quality
score. We considered weighting of the criteria based on
clinical importance, but this often adds complexity to the
analysis without providing insight into the clinical analysis
[72]. The total score was calibrated as a percentage to en-
able comparison and statistical analysis.
Subjective quality assessment
The panel of specialists also subjectively scored the treat-
ment pathway for each patient in two ways. Firstly, they
provided a quality rating of the treatment process on an or-
dinal scale of 1–10. Then, they assessed whether the treat-
ment pathway was appropriate with a yes/no response.
Positive predictive value of referral
Based on the method of Bennett et al. [73], we calcu-
lated the positive predictive value (PPV) of a referral.
This represents the chance of a referral leading to a rele-
vant diagnostic or management decision. Adapting this
concept from otolaryngology to a medical department,
we defined the PPV as the number of referrals that re-
sulted in a histological diagnosis, diagnostic clarification,
or change in medical management.
Adequacy of prioritization
Prior to including the patients, potential outcome diag-
noses within the four clinical areas were grouped into
four categories according to severity. As no prior classifi-
cation was found this was done by the main author
based on WHO International Statistical Classification of
Disease and Related Health problems 10th revision
(ICD-10) disease codes. The groupings were adjusted
after feedback from specialists within each clinical field.
Each patient was placed in a severity group based on the
final ICD-10 code from the hospital medical records. If
several codes were set for an individual patient the code
belonging to the most severe group was utilized. As an
example a final diagnosis of C18.2 (cancer in the ascend-
ing colon) would be placed in the most severe group
and a final pure symptomatic diagnosis of R19.4 (change
in bowel habit) would be placed in the least severe
group. When a diagnosis was encountered that could
not be categorized according to the pre-planned severity
grouping, consensus was achieved among the study or-
ganizers before putting it into the appropriate category.
This severity grouping was then used to compare the ad-
equacy of the waiting time between the intervention and
control groups. Waiting time was defined as the time
from the referral was received at the hospital until the
first out-patient appointment, measured in days.
Statistical methods
To assess scoring agreement for the main outcome, we
estimated repeatability coefficients [74]. We provide
plots of the mean for each pair of scores vs the differ-
ence in score between the two raters for the clinical
areas of chest pain and COPD (Bland-Altman plots). We
did not produce such plots for gastroenterological clin-
ical areas; as it was impossible to define primary and
secondary raters for the individual observational pairs
when eight raters overlapped, and Bland-Altman plots
depend on the sign of the difference between raters.
The cluster design of the present study demanded an
analysis that took into account the clustered nature of
the data [75]. In this study, we used multi-level regres-
sion modelling to evaluate the effect of the intervention
on the main outcome (quality indicator score). We
employed likelihood ratio tests to assess the appropriate-
ness of the model. To determine the effect of con-
founders to level one of the model, a change in the
regression coefficient for the intervention effect of >10%
was considered relevant. Based on prior assessment and
subject knowledge, we included patient gender, age, spe-
ciality status of hospital doctor, and severity of final
diagnosis in the model. We checked effect modification
for relevant variables using p < 0.05 as the significance
level. The CONSORT guideline for cluster randomised
trials was adhered to [75].
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For the subjective quality assessment, data are presented
as medians with interquartile ranges since the values were
not normally distributed. In addition, we employed multi-
level ordinal regression analysis to confirm the findings.
To assess PPV, we used a simple comparison of percenta-
ges—without correction for clustering.
We conducted the analyses throughout on an intention-
to-treat basis. With this analysis, patients referred from
intervention centres were regarded as belonging to the
intervention group—even if it was evident that the inter-
vention had not been used by the referring GP for that
particular patient. In all analyses the patient was the unit
of analysis and a two-level data structure was used.
Missing data
A small amount of data was missing from the outcome
scoring, representing 2/500 (0.4%) for the subjective
quality assessment score and 5/500 (1%) for the binary-
outcome of adequate treatment process. To allow for a
complete data-set analysis, these data were estimated.
For the subjective quality score, the two missing values
were set as the median value. For the binary outcome,
the response was set to yes (numerical value 1) for sub-
jective score values above six and no (numerical value 0)
for scores of five and under. Where both the subjective
and binary scores were missing, the median value was
used for the binary score (yes, numerical value 1).
Results
Baseline characteristics
In all, 500 patients were available for analysis in this study:
281 in the intervention arm and 219 in the control arm
after exclusion of nine in the intervention and eight in the
control arm [34]. No clusters were lost to follow up. There
were no significant baseline differences between the pa-
tients in the intervention and control arm, as seen in
Table 2. The majority of referrals were within the dyspep-
sia and suspected colorectal cancer clinical areas. More of
the GPs in the intervention than in the control group were
board certified GPs, but the years of experience were simi-
lar in both groups. Significantly more referrals in the inter-
vention arm were sent by female GPs, which probably
relates to the higher number of female GPs in the inter-
vention than in the control arm. Most referrals were elec-
tronic, but six paper referrals (2.7%) were received in the
control arm versus none in the intervention arm. Half
(49.5%) of the referrals in the intervention arm were sent
to the designated electronic address established for the
project; the rest were sent to the standard hospital elec-
tronic address.
Scorer agreement
A subsample of 86 care pathways was scored by two sep-
arate specialists to determine concordance between the
scorers. For the quality indicator score, the mean di-
fference between the two scoring measurements did not
significantly differ from 0, and estimation of the repeat-
ability coefficients, as suggested by Bland and Altman, is
presented in Table 3. These suggest a wide variation in
scoring between the different scorers. Bland-Altman
plots are presented in Fig. 1 for chest pain and COPD
since there were only two scorers. It is evident that for
chest pain, one of the scorers gave a much higher range
of scores than the other. In addition, there is quite
clearly a wide variation in scoring between the two
scorers for both clinical areas.
Using absolute values, the mean difference between the
scorers was 14% (95% confidence interval [CI], 11.6–16.4)
with a coefficient of variation of 80.6%.
For the subjective quality scoring, the repeatability co-
efficients were also high; Bland-Altman plots for the
chest pain and COPD clinical areas showed similar re-
sults, with wide variation in scoring (data not shown).
Quality indicator score
Average quality score, not adjusted for clustering, in the
intervention arm was 64.4% (95% CI, 62.4–66.3) and in
the control arm 60.0% (95% CI, 57.9–62.2); the averages
for each clinical area are presented in Table 4. Using a
baseline multi-level model with patients from all clinical
areas combined, the ICC was estimated at 0.02 (95%, CI
0.00–0.06). Adding a slope for the intervention status in-
creased the −2 log likelihood of the model and did not
make a large change in the residual variance. It was
therefore not retained in the model. Postulating a three
level data structure by allowing the results to vary ran-
domly at the level of the referring GP only marginally
reduced the −2 log likelihood and residual variance of
the model. The two level structure proposed in the
methods paper was therefore kept. No significant inter-
action was found. A significant effect of the intervention
was seen in the baseline model; however, after correction
for relevant confounders, the intervention effect was re-
duced to 1.80% (95% CI, −1.46 to 5.06, p = 0.280). Further
regression coefficients appear in Table 5. No clear viola-
tion of normality assumptions was noted. Additional mod-
elling for each individual rater revealed no significance of
the intervention for any rater (data not shown). Given the
significant difference (not corrected for clustering) shown
for the dyspepsia group in Table 4 modelling was also per-
formed for each of the four diagnostic groups. No signifi-
cant effect of the intervention was seen, after correction
for confounding factors (data not shown).
Subjective quality score
The subjective quality rating was done on an ordinal
scale of 1–10. As evident in Fig. 2, the variable was not
normally distributed. Overall, the median in the
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intervention arm and control arm was 8, with an inter-
quartile range of 2. Table 6 presents the median and
interquartile range by clinical area and intervention sta-
tus. No difference between the intervention and control
arms appeared in the graph or interquartile ranges. This
was confirmed with a multi-level ordinal regression
model, in which no difference was noted (data not shown).
No difference was observed between the intervention and
control arms in the binary(yes/no) assessment of patient
pathway appropriateness (data not shown).
PPV of referral
Table 7 shows the number of patients who had a hi-
stological diagnosis, diagnostic clarification, or change in
medical management as a result of their outpatient
Table 2 Selected baseline characteristics for patients and general practitioner surgeries by intervention statusa
Intervention group Control group p value
Patient demographics b
Female/male, n (%) 166 (59.1)/115 (40.9) 127 (58.0)/92 (42.0) 0.807
Age, years 59.2 ± 13.6 57.1 ± 15.3 0.101
Urban/rural, n (%) 169 (60.1)/112 (39.9) 121 (55.3)/98 (44.7) 0.272
Clinical group, n (%)
- Dyspepsia 144 (51.3) 120 (54.8)
- Suspected colonic malignancy 87 (31.0) 68 (31.1)
- Chest pain 46 (16.4) 27 (12.3)
- COPDc 4 (1.4) 4 (1.8)
Hospital appointment with senior
house officer/specialist, n (%)
130 (46.3)/151 (53.7) 96 (43.8)/123 (56.2) 0.588
Given right to health care after
assessment of referral, yes/no, n (%) d
222 (79.0)/59 (21.0) 168 (76.7)/51 (23.3) 0.587
GP surgery variablesb
List size 830.8 ± 208.8 865.5 ± 100.7 0.475
Female/male GP, n (%) 14 (58.3)/10 (41.7) 10 (43.5)/13 (56.5) 0.308
Board certified, yes/no, n (%) 18 (75.0)/6 (25.0) 11 (47.8)/12 (52.2) 0.055
Years experience 16.0 ± 10.4 15.2 ± 11.2 0.784
Number of GPs in surgery 4.3 ± 1.6 4.0 ± 1.6 0.536
- Median 5 5
- Mode 5 5
GP referral variables per referral in data setb
Female/male referring GP, n (%) 182 (64.8)/99 (35.2) 93 (42.5)/126 (57.5) <0.00001
Number of GPs in surgery 4.4 ± 1.5 4.0 ± 1.6 0.003
Specialist, yes/no n (%) 189 (67.3)/92 (32.7) 114 (52.1)/105 (47.9) 0.000556
Years experience 16.2 ± 12.0 15.4 ± 11.7 0.456
Other variables per referral in data setb
Electronic/paper referral, n (%) 281 (100)/0 (0) 213 (97.3)/6 (2.7) 0.005
aTwo GPs shared two lists at two separate surgeries, both in the intervention group. Weighted analysis that took this into account did not lead to significant
changes in the baseline characteristics
bData are presented as mean ± SD or number (%)
cCOPD chronic obstructive pulmonary disease
dAfter assessment of the referral Norwegian hospital doctors decided whether or not a patient had a legal “right to health care” within a given time
Table 3 Repeatability coefficient overall and for the four clinical
areas
Area Repeatability
Coefficient
Overall +/− 35.18
Dyspepsia (n = 44) +/− 40.71
Colorectal (n = 17) +/− 23.20
Chest pain (n = 17) +/− 20.25
COPD (n = 8) +/− 46.68
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appointment. There were some missing items: this was
because part of the scoring sheet with the PPV scoring
box appeared on a separate page and may therefore have
been overlooked. No clear difference was evident be-
tween the intervention and control arms.
Adequacy of prioritization
The average waiting time (time from referral to first out-
patient appointment) was 46 days (95% CI, 42–50) in
the intervention arm and 49 days (95% CI, 43–55) in the
control arm (p = 0.364, t test). The waiting times for the
four separate clinical areas appear in Table 8, with no
significant differences between the intervention and con-
trol arms. The large difference in the COPD area is due
to small numbers (N = 8) and random difference. The
average waiting time stratified by intervention or control
status and severity of final diagnosis is presented in
Table 9. No significant differences were observed be-
tween the intervention and control arms. In addition, no
definite trend was seen in the waiting time across sever-
ity groups—except that the waiting time was signifi-
cantly shorter for patients with a final diagnosis classed
as “very severe” than with the three other severity group-
ings (p = 0.01, t test). These average values are not cor-
rected for clustering; however, a simple multi-level
model with waiting time as the outcome variable and
intervention status as predictor suggested very little
effect of clustering, with an estimated ICC of
<0.00001. In addition, allowing for clustering in the
estimation of the mean led to narrower CIs, which is
counterintuitive.
Waiting time was not normally distributed. To assess
further the effect of the intervention on prioritization,
we divided waiting times into deciles and used ordinal
logistic regression, with waiting times in deciles as the
dependent variable and severity group as predictor. We
conducted a separate analysis for the intervention and
control arms. This suggested a significant trend in the
control arm only, as shown in Table 10. However, the
significant effect found in the control arm did not persist
if the variable waiting time was divided into ten groups
with set intervals (41, 82, 123 … 410) rather than deciles.
By way of sensitivity analysis, we also checked the ana-
lysis using a multi-level model; however, this did not
represent the data significantly better, and so for simpli-
city we retained the one-level model. Also, standard lin-
ear regression did not show any significant variation in
waiting time based on the severity score (data not
shown); this, though, should be interpreted with caution
since the variable was not normally distributed.
Discussion
In the present study, we aimed to assess whether imple-
menting a referral intervention would lead to improved
quality of care for medical outpatients. We have previ-
ously shown that the referral quality did increase [34],
however there was no clear effect on the quality indica-
tor score, subjective quality score, or PPV of referrals, as
detailed above. In addition, there was no evidence that
improving referrals enhanced prioritization at the hos-
pital; in one analysis, prioritization even seemed more
precise in the control arm. Hence, it would appear that
the use of referral templates did not generate a clear
clinical benefit for the individual patients.
In addition to the study limitations discussed below,
several factors may explain the lack of effect. First, it is
possible that care for patients has improved but that the
measurement instruments and outcomes have been un-
able to quantify it. Guidelines and clinical practice allow
Fig. 1 Bland-Altman plot for quality indicator score for area chest pain and chronic obstructive pulmonary disease (COPD)
Table 4 Average quality score per diagnostic group, not
corrected for clusteringa
Intervention Control p value
Dyspepsia 62.0 (59.2–64.8) 57.2 (54.1–60.3) 0.023
Suspected colorectal
malignancy
65.0 (61.5–68.3) 61.4 (58.3–64.5) 0.138
COPD 48.3 (11.9–84.7) 51.0 (29.0–73.0) 0.847
Chest pain 72.1 (68.5–75.7) 70.8 (65.2–76.4) 0.669
aPresented as mean and 95% confidence interval
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some flexibility for the treating clinician, whereas quality
criteria often are rigid [76]. Thus, an ideal patient
pathway—as was the goal in this study—will not neces-
sarily be represented by 100% adherence to any given set
of quality criteria; there will always be some level of sub-
jectivity in the assessment of quality for each individual
patient pathway. In future studies, therefore, even more
effort is necessary to develop precise, valid outcomes
measures to ensure that any potential effect is docu-
mented. The use of a mixed-methods approach may also
help identify improvements that are hard to quantify;
such an approach is regarded as especially useful in
health services research [77]. Second, it is possible that
the referrals in the control arm were of sufficiently high
quality to ensure adequate referral assessment and
prioritization at baseline. As such, the scope for im-
provement was small and therefore difficult to measure.
As such further studies in areas with more varied refer-
ral quality may allow the effects of referral interventions
to be quantified more precisely. Third, referrals are only
part of the complex care pathway, and it is possible that
improvement of only one part is insufficient to result in
quantifiable improvements of the entire process. Other
factors—medical, organizational, and individual—may
also govern the process.
We have been unable to locate many comparable stud-
ies that aimed to assess the effect of a referral interven-
tion on the further patient pathway in hospital—a
shortcoming also addressed in a Cochrane review on re-
ferral intervention [31]. There are, however, some excep-
tions, with limited findings that are in line with those of
the current project. In a UK study a referral intervention
led to improved referral content, but it did not increase
the amount of organic pathology revealed among those
referred for colonoscopy. The authors commented that
the value of the intervention may have been reduced by
limited uptake [78]. In the study by Bennett et al. noted
Table 5 Effect estimates for intervention on quality score
Regression
coefficient
95% CI p value
Crudea 4.33 1.39–7.27 0.004
Adjustedb 1.80 −1.46–5.06 0.280
- Patient gender (male) 1.43 −1.45–4.32 0.330
- Patient age (centred) 0.05 −0.05–0.15 0.314
- Doctor in trainingc vs.
specialist
−5.40 −8.21 to −2.60 <0.001
- Severity of final diagnosis 0.001*
- Not severed
- Less severe 3.20 0.11–6.29
- Severe 6.20 1.70–10.69
- Very severe 8.44 −0.17 to 17.05
- Quality of referral 0.09 0.03–0.15 0.004
aBaseline model with intervention effect and random intercept
bAdjusted for variables listed in table
cDoctor in training (resident) reference
dReference
*p value for trend
Fig. 2 Subjective quality score (1–10) for intervention and control groups
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above, more appropriate patients were referred, but no
information was presented regarding hospital manage-
ment [73]. In a urology study, the implementation of
education meetings and referral guidance led to a reduc-
tion in waiting time and an increase in the probability of
receiving a management decision at the first appoint-
ment, but no difference in patient outcomes was found
[79]. In Norwegian mental health services, a study is un-
derway attempting to explore the effect of the quality of
referrals on patient and organizational outcomes [80].
One way of promoting the use of referral interventions
would be to make them a mandatory part of the referral
process: they could appear as drop-down menus to-
gether with the relevant clinical information. This pro-
cedure would remove problems with uptake of the
intervention and enable a more precise determination of
the intervention effects. However, the present study
found no clear effect of the referral templates, and, as
seen in Tables 9 and 10, the prioritization was equally
good in the control arm. It therefore seems that there
are factors other than the pure informational quality in
the referrals that guide the hospital clinician in identify-
ing the most ill patients. It is possible that more subtle
clinical details would disappear if the ability to enter free
text were completely removed. Hence, the full imple-
mentation of obligatory referral guidance should occur
only after further assessment has shown it to be of clin-
ical importance.
This study found no significant effect of the interven-
tion. We included at total of 500 patients, with 281 in
the intervention and 219 in the control arm. Given the
sample size indicated above this means that the study
was well powered to detect the 10% change in the qual-
ity indicator score that was set as clinically interesting;
hence, the risk of a type II error is low. The power calcu-
lations do, however, underline the need to increase clus-
ter numbers, rather than cluster size, to increase the
power of cluster-randomized studies [81]. The current
study would have been underpowered if the ICC had
been at the upper end of the confidence interval of the
ICC, regardless of how many patients were recruited.
Strengths and limitations
Certain aspects regarding recruitment and use of the
intervention may have hampered the results. The aim of
the study was to investigate the use of referral templates
in actual clinical practice. In this real-world scenario, it
would be pertinent to determine how many of the po-
tential participants were actually recruited. Exact infor-
mation about this would have required manual searches
of outpatient lists and relevant electronic journals—this
Table 6 Median of subjective total scorea
Intervention Control
Dyspepsia 8 (2) 7.5 (3)
Suspected colorectal
malignancy
9 (2) 9 (2)
COPD 4 (7) 4.5 (5)
Chest pain 8 (2) 8 (2)
aPresented as median and interquartile range
Table 7 Tabulation of positive predictive value (PPV) of referral,
not corrected for clusteringa, b
Intervention Control
Histological diagnosisc
- Yes 86 (37.2) 67 (35.6)
- No 137 (59.3) 112 (59.6)
- Missing 8 (3.5) 9 (4.8)
Diagnostic clarification
- Yes 220 (78.3) 164 (74.9)
- No 51 (18.2) 46 (21.0)
- Missing 10 (3.5) 9 (4.1)
Change in medical
management
- Yes 154 (54.8) 105 (48.0)
- No 117 (41.6) 105 (48.0)
- Missing 10 (3.6) 9 (4.1)
PPV total
- Yes 243 (86.5) 183 (83.6)
- No 28 (10.0) 27 (12.3)
- Missing 10 (3.5) 9 (4.1)
aNumbers are presented as positive outcomes in absolute numbers
and percentages
bNo significant differences seen between intervention and control groups
cOnly for the clinical areas of dyspepsia and suspected CRC (not relevant for
COPD and chest pain), n = 419
Table 8 Average waiting time by clinical areaa
Clinical area Intervention group Control group
Dyspepsia 41 (28.6) 47 (46.3)
Suspicion of CRC 40 (31.4) 43 (37.5)
Chest pain 69 (42.5) 69 (39.1)
COPD 108 (59.6) 78 (44.3)
a Numbers are days (rounded to whole days) with SD in brackets; no
significant differences between intervention and control groups
Table 9 Average waiting time by severity of final diagnosis a
Severity of final diagnosis Intervention group Control group
Not severe (n = 190) 47 (35.4) 53 (40.6)
Less severe (n = 227) 45 (32.3) 49 (49.1)
Severe (n = 68) 55 (42.8) 41 (31.8)
Very severe (n = 15) 22 (14.0) 26 (17.7)
aNumbers are days (rounded to whole days) with SD brackets; no significant
differences between intervention and control groups
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was incompatible with the ethical approval for the pro-
ject and current legal regulations. However, indirect evi-
dence indicates that 60% of potential patient participants
were recruited. We have no indication that this figure
varied between the intervention and control arms. Al-
though we have no indication that the current sample
differs from those not recruited the study did not assess
this formally due to the constraints mentioned above. In
addition, it is not clear how often the referring GPs ac-
tively utilized the intervention when initiating new refer-
rals. The designated electronic project address was used
approximately 50% of the time, which suggests a fairly
modest uptake, although higher than in other studies [78].
This is likely to have attenuated the intervention effect
since intention-to-treat analysis was employed. In total,
these aspects are unlikely to have led to a significant selec-
tion bias, but may have attenuated the intervention effect.
The high variation in scoring among the scorers limits
the applicability of the statistical analysis. This study opted
to use numerous assessors, instead of just a few, to achieve
a manageable assessment workload. The result was that a
wide variety of scorers from different hospitals and clinical
cultures took part. To try and ensure the validity of the
conclusions, we performed subanalyses and ran the models
individually for each rater. This of course yielded higher
CIs, but the overall effects retained the same sign and mag-
nitude. This was not suprising as the raters were given a
mix of control and intervention patient pathways for scor-
ing. We therefore feel that although the variation may limit
the generalizability of the measurement instruments, it does
not necessarily invalidate the conclusions of this study.
Since health-care quality is not a defined physical entity
or even a clearly defined concept, it will always be difficult
to measure precisely. Many authors have tried to measure
quality of care and hospital quality and have used various
ways, even Facebook [82]. The development of quality cri-
teria is often challenging and should be based on accepted
standards of care using sound evidence [83]. What is being
measured should also represent an important aspect of care
for the particular condition. In addition, an indicator has to
be clearly defined, and the information must be available
[83]. Most criteria in use today are accountability measures,
designed to measure adherence to specific actions and
employed for accreditation or reimbursement [24, 84]. In
the present study, process indicators were developed for
the care of patient groups, who ended up with a plethora of
diagnoses instead of clearly defined diagnostic groups with
simple measurements. This approach is clearly in line with
the aim of this study, which was to investigate the use of re-
ferral guidance in normal clinical practice. Accordingly, it
may be seen as reflecting a strength of the study. However,
it added complexity to the development of the study out-
come criteria. The criteria employed in this study do not,
therefore, fulfil all requirements of ideal process criteria;
overall, however, they represent an attempt to quantify the
quality in everyday clinical practice at the level of the indi-
vidual patient. This limits comparability with other studies,
but we believe that this approach was more likely to iden-
tify the effects of referral intervention since such effects
were expected to be subtle rather than obvious.
Another potential limitation is the quality of the
source of clinical information. Hospital records were
used to obtain the relevant information. Implicitly,
this study did not therefore measure if a certain ac-
tion was performed, but whether the action was per-
formed and documented. Whereas the prospective
collection of information from electronic health re-
cords is the most thorough way of acquiring informa-
tion [85], the quality of medical records has been
debated for some time [86–88]. Electronic health re-
cords have facilitated documentation, but the quality and
completeness of the data is still under debate [89]. How-
ever, information gathering and assessment were per-
formed the same way for both the intervention and
control arms, and there was no indication that the manner
of documentation gathering led to information bias.
The main strength of the present study is closely re-
lated to its weaknesses. This study was performed in a
normal clinical setting without major intervention at any
level other than the referral. This real-life approach
should ensure that the results are applicable for many
other health-care settings where referral from the GP to
the hospital specialist is the norm.
Conclusions
This cluster-randomized trial was designed to assess the
impact of a referral intervention on the quality of care
and hospital management of patients. No measurable
effect on quality of care or prioritization of patients was
found. The results were hindered by a limited uptake of
the intervention at GP surgeries and inconsistencies in
outcome assessment. It seems reasonable to assume that
more information in the referral will improve further
management, but more stringent assessment may, in
future research, be necessary.
Table 10 Ordinal regression of waiting time (in deciles) versus
severity of final diagnosis
Severity of final
diagnosis
Regression coefficient
intervention group *
Regression coefficient
control group **
Not severe a
Less severe −0.77 (−0.53 to 0.38) −0.33 (−0.84 to 0.17)
Severe .41 (−0.24 to 1.06) −0.59 (−1.32 to 0.14)
Very severe −1.42 (−2.41 to −0.42) −1.90 (−4.06 to 0.27)
aReference category
*p = 0.333 for trend
**p = 0.032 for trend
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